Description
Sermorelin peptides are synthetic forms of the first 29 amino acids of human growth hormone-releasing hormone. This sequence represents the biologically active N-terminal portion of GHRH and is commonly identified as growth hormone-releasing factor (1-29) amide. FDA substance records describe sermorelin as a 29-amino-acid peptide associated with growth hormone-releasing factor activity.
Sermorelin research focuses on GHRH receptor signaling, pituitary-related pathways, growth hormone release mechanisms, endocrine signaling, and downstream IGF-related activity in controlled experimental systems. The term sermorelin peptide therapy is sometimes used in commercial or clinical contexts, but Super Serumz products are positioned strictly for laboratory research and should not be represented as treatments or therapeutic products.
Features
- Composition: Synthetic 29-amino-acid peptide
- Structural Origin: Corresponds to residues 1-29 of human GHRH
- Alternative Name: Growth hormone-releasing factor (1-29) amide
- Research Classification: GHRH analog
- Molecular Weight: Approximately 3,357.9 Da for the peptide sequence
- Research Focus: GHRH receptor activity, pituitary signaling, endocrine pathways, growth hormone release mechanisms, and downstream cellular signaling
- Laboratory Application: Controlled peptide, receptor, and endocrine pathway research
- Format: Supplied as lyophilized research material
- Recommended Storage: −20 °C unless otherwise specified in batch documentation
Disclaimer: Supplied strictly for laboratory research. Not intended for human or veterinary use, administration, consumption, diagnosis, treatment, or therapeutic purposes.
Reviews
There are no reviews yet.